TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1320913

Group type: EXPERIMENTAL
Intervention: Granisetron (40 micrograms/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metoclopramide (3 mg/kg) plus dexamethasone (12 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chlorpromazine (up to 200 mg/24 h) plus dexamethasone (12 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparator groups
Number of subjects: 40
Study: 6483068

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Methylprednisolone
Number of subjects: 20
Study: 31174710

Group type: EXPERIMENTAL
Intervention: Intervention condition (various intensities)
Number of subjects: 602
Study: 30391914

Group type: EXPERIMENTAL
Intervention: Continuous infusions of vancomycin (CIV)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intermittent infusions of vancomycin (IIV)
Number of subjects: 200
Study: 25782451

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Post-operative patients (24-48 h after catheter ablation)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Followed-up patients (58.52 ± 36.00 days after catheter ablation)
Number of subjects: 100
Study: 25156622

Group type: EXPERIMENTAL
Intervention: Alemtuzumab (30 mg intraoperatively)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Rabbit anti-thymocyte globulin (multiple doses starting intraoperatively)
Number of subjects: 46
Study: 21210862

Group type: COMPARATOR
Intervention: Control group (2 kg/(calf × day) of concentrate)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Restricted group (1 kg/(calf × day) of concentrate)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 20180945

Group type: EXPERIMENTAL
Intervention: in‐tune fast music
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: out‐of‐tune fast music
Number of subjects: 75

Group type: COMPARATOR
Intervention: background music (various conditions)
Number of subjects: 75
Study: 17914568

Group type: EXPERIMENTAL
Intervention: Gln/Gln genotype in CRC patients (18.0%)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Gln/Gln genotype in well-differentiated grade CRC patients
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Gln/Gln genotype in lymph node metastasis (N1) CRC patients
Number of subjects: 300

Group type: COMPARATOR
Intervention: Healthy controls with no CRC (11.5%)
Number of subjects: 300
Study: 16103688

Group type: EXPERIMENTAL
Intervention: rBet v 1 trimer
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: rBet v 1 fragments
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo-aluminium hydroxide
Number of subjects: 27
Study: 12097201

Group type: EXPERIMENTAL
Intervention: Radioiodine and lithium group (Li group) - lithium carbonate, 300 mg three times a day for 3 weeks starting on the day of radioiodine administration
Number of subjects: 350

Group type: COMPARATOR
Intervention: Radioiodine group (controls) - no lithium given
Number of subjects: 350
Study: 9858319

Group type: EXPERIMENTAL
Intervention: Betaseron (8 MIU every other day s.c.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: AVONEX (6 MIU single i.m. dose)
Number of subjects: 16
Study: 7561225

Group type: EXPERIMENTAL
Intervention: Physicians' knowledge of NSAID prices
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Cost consideration by physicians
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Pharmacy price variation
Number of subjects: 95
Study: 2236452

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 1011271

Group type: EXPERIMENTAL
Intervention: Biofeedback on rate and amplitude of tumescence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biofeedback techniques
Number of subjects: 0
Study: 31794239

Group type: EXPERIMENTAL
Intervention: Virtual Alcohol Approach‐Avoidance Training Task
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham training condition
Number of subjects: 28
Study: 29019297

Group type: EXPERIMENTAL
Intervention: OPTI-SCRIPT intervention
Number of subjects: 196
Study: 25682064

Group type: EXPERIMENTAL
Intervention: Moderate low-carbohydrate diet (M-LCD) for 3 months
Number of subjects: 76
Study: 22503722

Group type: EXPERIMENTAL
Intervention: Ca-group: 500 mg/d calcium
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Ca+MZ-group: 500 mg/d calcium + multivitamin tablet containing 15 mg/d zinc
Number of subjects: 214

Group type: COMPARATOR
Intervention: C-group: multivitamin tablet without any minerals
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Ca-group and Ca+MZ-group
Number of subjects: 214
Study: 20435196

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 1442

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 1442

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 1442

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1442
Study: 18469027

Group type: EXPERIMENTAL
Intervention: Telephone counselling
Number of subjects: 366
Study: 12905544

Group type: EXPERIMENTAL
Intervention: Three-layer paste bandages
Number of subjects: 133

Group type: COMPARATOR
Intervention: Four-layer bandages
Number of subjects: 133
Study: 10681870

Group type: EXPERIMENTAL
Intervention: Tonifying the kidney with improving blood circulation
Number of subjects: 141

Group type: COMPARATOR
Intervention: Tonifying the kidney alone
Number of subjects: 141
Study: 8618250

Group type: EXPERIMENTAL
Intervention: Urinary alkalinization for 24 hours
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Multiple-dose activated charcoal (six doses) and two doses of sorbitol over 24 hours
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no interventions)
Number of subjects: 10
Study: 1741720

Group type: EXPERIMENTAL
Intervention: Low fat (LF) group
Number of subjects: 24

Group type: COMPARATOR
Intervention: High fat (HF) group
Number of subjects: 24
Study: 6289856

Group type: EXPERIMENTAL
Intervention: Premedication with diazepam 5 mg rectally and atropine 0.3‐0.4 mg sublingually (Group A)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Rectal combination of diazepam 0.5 mg kg‐1, morphine 0.15 mg kg‐1 and hyoscine 0.01 mg kg‐1 (Group B)
Number of subjects: 14
Study: 30356311

Group type: EXPERIMENTAL
Intervention: Structured discussion condition with instructor guidance
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Interpolated testing condition with test questions throughout the video
Number of subjects: 99

Group type: COMPARATOR
Intervention: Baseline condition of watching the video as in current practice
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Spontaneous discussion condition without guidelines
Number of subjects: 99
Study: 26879200

Group type: EXPERIMENTAL
Intervention: Odanacatib (ODN) 50 mg weekly for up to 8 years
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Odanacatib (ODN) 50 mg weekly for up to 8 years with vitamin D3 (5600 IU) and calcium supplementation
Number of subjects: 117
Study: 24604584

Group type: EXPERIMENTAL
Intervention: IMT-HI
Number of subjects: 45

Group type: COMPARATOR
Intervention: IMT-E
Number of subjects: 45
Study: 21881529

Group type: EXPERIMENTAL
Intervention: 30-second rest interval
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 60-second rest interval
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 120-second rest interval
Number of subjects: 30
Study: 20206540

Group type: EXPERIMENTAL
Intervention: Minimised perfusion circuit (MPC)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass (CCPB)
Number of subjects: 291
Study: 17846812

Group type: EXPERIMENTAL
Intervention: Methylphenidate Spheroidal Oral Drug Absorption System (MPH-SODAS)
Number of subjects: 62
Study: 15902741

Group type: EXPERIMENTAL
Intervention: rhGH and lactulose
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 14533282

Group type: EXPERIMENTAL
Intervention: Home-based training after initial hospital walking training (n = 14)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (n = 12)
Number of subjects: 26
Study: 10390392

Group type: EXPERIMENTAL
Intervention: Aerosolized uridine-5'-triphosphate (UTP) 5 mg/ml, 3.5 ml
Number of subjects: 12

Group type: COMPARATOR
Intervention: Vehicle (0.12% saline, 3.5 ml)
Number of subjects: 12
Study: 9071082

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (2.5 mg in 3 ml)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nebulized metaproterenol (15 mg in 3 ml)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nebulized saline 3 ml (control group)
Number of subjects: 30
Study: 1864451

Group type: EXPERIMENTAL
Intervention: 0.5 g/day Imedeen for 90 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo for 90 days
Number of subjects: 10
Study: 6401426

Group type: EXPERIMENTAL
Intervention: Intranasal nitroglycerine (NTG) administered 1 min before induction of anaesthesia
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no NTG)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups (NTG and Control)
Number of subjects: 35
Study: 31421659

Group type: EXPERIMENTAL
Intervention: Nebulized MgSO4
Number of subjects: 33

Group type: COMPARATOR
Intervention: Nebulized ipratropium bromide/fenoterol
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study: 30716509

Group type: EXPERIMENTAL
Intervention: SI! Program (curriculum‐based educational program over 3 or 6 academic years)
Number of subjects: 1770

Group type: COMPARATOR
Intervention: Standard curriculum (control group)
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: SI! Program
Number of subjects: 1770
Study: 30286760

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BJ) 70 ml (6.5 mmol NO3‐)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 12
Study: 26712474

Group type: EXPERIMENTAL
Intervention: Unscheduled health care visits for asthma or use of oral corticosteroids in the previous year
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Forced expiratory volume in 1 second (FEV1)
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Pre- and post-bronchodilator ratios of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC)
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Symptom scores on validated questionnaires
Number of subjects: 718
Study: 25161182

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 21966995

Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg (with optional dose escalation to 8 mg at week 4)
Number of subjects: 943

Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg
Number of subjects: 943

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 943
Study: 20300709

Group type: EXPERIMENTAL
Intervention: Prevention programs and interventions in the field of drug abuse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized evaluation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre‐post assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational approach for evaluation
Number of subjects: 0
Study: 17950801

Group type: EXPERIMENTAL
Intervention: 300 mg dabigatran plus aspirin
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: 150 mg dabigatran
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: 300 mg dabigatran
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: 50 mg dabigatran
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Dabigatran (50 mg, 150 mg, 300 mg)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 502
Study: 15973094

Group type: COMPARATOR
Intervention: No axillary dissection
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Axillary dissection
Number of subjects: 219
Study: 12089124

Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler (MDI) plus spacer (400 microg, 4 puffs)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Small Volume Nebuliser (SVN) (0.15 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both methods (MDI plus spacer and SVN)
Number of subjects: 12
Study: 10480520

Group type: EXPERIMENTAL
Intervention: Gonadal androgens (testosterone and androstenedione)
Number of subjects: 28
Study: 7497601

Group type: EXPERIMENTAL
Intervention: Carboplatin 42 mg/m2 per day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Carboplatin 35 mg/m2 per day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Carboplatin (all doses)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 18
Study: 1645990

Group type: EXPERIMENTAL
Intervention: Anesthetic solutions with added sodium bicarbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anesthetic solutions without added sodium bicarbonate
Number of subjects: 0
Study: 7021261

Group type: EXPERIMENTAL
Intervention: Flufenamic acid, 100 mg, four times daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Paracetamol (up to 8 x 500 mg daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Flufenamic acid
Number of subjects: 40
Study: 30266874

Group type: EXPERIMENTAL
Intervention: Intervention not specified
Number of subjects: 1169

Group type: EXPERIMENTAL
Intervention: Inpatient or outpatient episodes of diarrhoea and inpatient severe pneumonia during follow-up
Number of subjects: 1169

Group type: EXPERIMENTAL
Intervention: Premature birth and not being cared by the biological parent
Number of subjects: 1169

Group type: EXPERIMENTAL
Intervention: Increase in mid-upper arm circumference and weight-for-age
Number of subjects: 1169

Group type: EXPERIMENTAL
Intervention: Increase in weight-for-height
Number of subjects: 1169

Group type: EXPERIMENTAL
Intervention: Interventions to improve dietary quality and prevent illness
Number of subjects: 1169
Study: 27524815

Group type: EXPERIMENTAL
Intervention: Personalized nutrition advice
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Conventional dietary advice (control)
Number of subjects: 1269
Study: 27552352

Group type: EXPERIMENTAL
Intervention: High-Power Pain Threshold (HPPT) ultrasound therapy
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 61
Study: 24956454

Group type: EXPERIMENTAL
Intervention: Reader + DST (n = 16)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (n = 15)
Number of subjects: 31
Study: 22993332

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 573

Group type: COMPARATOR
Intervention: Physical activity (PA)
Number of subjects: 573
Study: 18704569

Group type: EXPERIMENTAL
Intervention: Four-pass transjugular liver biopsy (TJLB)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Three-pass transjugular liver biopsy (TJLB)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Four-pass TJLB with cassette
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Four-pass TJLB without cassette
Number of subjects: 92
Study: 17305652

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) 4 mg for 2 months and then 8 mg daily
Number of subjects: 555

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG)
Number of subjects: 555
Study: 15085323

Group type: EXPERIMENTAL
Intervention: povidone-iodine 10% (PVP-iodine)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: chlorhexidine 0.5%/propanol 70%
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: chlorhexidine 0.5%/propanol 70% followed by PVP-iodine 10%
Number of subjects: 119
Study: 12029412

Group type: EXPERIMENTAL
Intervention: Slow endotracheal surfactant infusion
Number of subjects: 14

Group type: COMPARATOR
Intervention: Bolus administration of surfactant
Number of subjects: 14
Study: 9836210

Group type: EXPERIMENTAL
Intervention: Alfentanil 15 micrograms.kg‐1 followed by propofol 4 mg.kg‐1 with lignocaine 0.2 mg.kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microgram.kg‐1 followed by propofol 4 mg.kg‐1 with lignocaine 0.2 mg.kg‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alfentanil and Remifentanil
Number of subjects: 40
Study: 8136941

Group type: EXPERIMENTAL
Intervention: Routine early amniotomy
Number of subjects: 1463

Group type: COMPARATOR
Intervention: Delayed amniotomy (intact membranes)
Number of subjects: 1463
Study: 2508524

Group type: EXPERIMENTAL
Intervention: Low dose aspirin
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 962994

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy and specific active immunotherapy (C+I)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Combination chemotherapy (C)
Number of subjects: 56
Study: 31233541

Group type: EXPERIMENTAL
Intervention: Compliant flooring (2.54 cm SmartCells)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Rigid control flooring (2.54 cm plywood)
Number of subjects: 184
Study: 27717706

Group type: EXPERIMENTAL
Intervention: 3D direct visualization
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard 2D laparoscopy
Number of subjects: 15
Study: 25448491

Group type: EXPERIMENTAL
Intervention: Conventional chemotherapy plus lenalidomide (DLBCL-len)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Conventional chemotherapy (DLBCL-c)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Patients with lenalidomide-induced hypothyroidism
Number of subjects: 329
Study: 23883653

Group type: EXPERIMENTAL
Intervention: Renal denervation on top of medical treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medical treatment alone
Number of subjects: 60
Study: 21545769

Group type: EXPERIMENTAL
Intervention: Experimental group fitted with Siemens Artis 2 SP BTE hearing aids, transitioning to NAL-RP targets over 15 weeks.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group maintained initial settings throughout the study.
Number of subjects: 23
Study: 19032600

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Repeated eccentric exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: First-bout eccentric exercise
Number of subjects: 14
Study: 16715187

Group type: EXPERIMENTAL
Intervention: Gadolinium mixed with 1:3 iohexol
Number of subjects: 42

Group type: COMPARATOR
Intervention: Iodine (iohexol) only
Number of subjects: 42
Study: 15367069

Group type: EXPERIMENTAL
Intervention: Tailored print and video (TPV) intervention
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Tailored print and video (TPV) intervention among those 50 and older (n = 287)
Number of subjects: 587

Group type: COMPARATOR
Intervention: Lay health advisor (LHA) intervention
Number of subjects: 587
Study: 11742335

Group type: EXPERIMENTAL
Intervention: Minimally invasive video-assisted thyroidectomy (MIVAT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional thyroidectomy (CT)
Number of subjects: 49
Study: 9006472

Group type: EXPERIMENTAL
Intervention: Nurse run clinic
Number of subjects: 251

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 251
Study: 8235664

Group type: EXPERIMENTAL
Intervention: 10MTX (10 mg/M2/wk)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520

Group type: COMPARATOR
Intervention: D-penicillamine (10 mg/kg/d)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Hydroxychloroquine (6 mg/kg/d)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Auranofin (0.15 to 0.20 mg/kg/d)
Number of subjects: 520

Group type: COMPARATOR
Intervention: 5MTX (5 mg/M2/wk)
Number of subjects: 520
Study: 3316278

Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 31362999

Group type: EXPERIMENTAL
Intervention: Black garlic with Lactobacillus bulgaricus (BG)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Black garlic (CG)
Number of subjects: 226
Study: 27803033

Group type: EXPERIMENTAL
Intervention: Bevacizumab, cisplatin, and paclitaxel (bevacizumab 15 mg/kg, cisplatin 50 mg/m2, paclitaxel 135 mg/m2 over 24 h or 175 mg/m2 over 3 h) administered every 3 weeks until disease progression or unacceptable toxicity.
Number of subjects: 7
Study: 25475358

Group type: EXPERIMENTAL
Intervention: Phenylephrine 10 mg with acetaminophen 1000 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Phenylephrine 10 mg with acetaminophen 500 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Phenylephrine 5 mg with acetaminophen 1000 mg
Number of subjects: 90
Study: 24067392

Group type: EXPERIMENTAL
Intervention: Half a gold kiwifruit (Actinidia Chinensis var. Hort 16A) per day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vitamin C tablet (50 mg)
Number of subjects: 36
Study: 21565490

Group type: EXPERIMENTAL
Intervention: OFF (oxaliplatin, folinic acid, and 5-fluorouracil)
Number of subjects: 46

Group type: COMPARATOR
Intervention: BSC (Best Supportive Care)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: GEM-OFF (Gemcitabine followed by OFF)
Number of subjects: 46

Group type: COMPARATOR
Intervention: GEM-BSC (Gemcitabine followed by BSC)
Number of subjects: 46
Study: 18270132

Group type: EXPERIMENTAL
Intervention: Glutamate/aspartate supplementation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Crystalloid cardioplegia (Control)
Number of subjects: 70
Study: 17138710

Group type: EXPERIMENTAL
Intervention: Chemomechanical caries removal (CMCR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional method (TM)
Number of subjects: 50
Study: 15575172

Group type: EXPERIMENTAL
Intervention: Topical calcipotriol (50 microg/gm cream applied twice daily)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Topical calcipotriol (ointment)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Topical calcipotriol
Number of subjects: 18
Study: 11052493

Group type: COMPARATOR
Intervention: Nonsteroidal anti-inflammatory drug, acetaminophen, or placebo for 2 weeks
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Increased pain
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Decreased pain
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Unchanged pain
Number of subjects: 53
Study: 9352449

Group type: EXPERIMENTAL
Intervention: Mitral annulus calcification
Number of subjects: 1219

Group type: COMPARATOR
Intervention: Control group (without mitral annulus calcification)
Number of subjects: 1219

Group type: EXPERIMENTAL
Intervention: Hypertension and carotid atheroma
Number of subjects: 1219
Study: 8257447

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg daily)
Number of subjects: 24